.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Siemens Healthineers is planning a significant exit from the American Oncology Institute (AOI). This move highlights shifting priorities in cancer care investment India and broader healthcare strategies. The company has reportedly engaged Alvarez & Marsal to manage the multi-crore deal. Currently, AOI operates 16 hospitals across India with a 500-bed capacity.
Siemens considers the AOI hospital network a non-core asset. Therefore, they aim to focus on diagnostic and therapeutic imaging instead. This potential sale aligns with global plans to streamline their portfolio. Bloomberg previously reported talks regarding a $7 billion sale of their diagnostic business. Consequently, the company is refocusing on its primary technological strengths.
The Indian cancer care market shows rapid expansion today. It reached a value of ₹1.25 lakh crore in 2024. Furthermore, analysts expect a CAGR of 10-12% over the coming years. Several private equity funds are showing interest in this acquisition. Healthcare Global Enterprises (HCG) has also been sounded out as a potential bidder. This trend demonstrates high investor confidence in specialized oncology services.
Q1: What is the estimated valuation of the American Oncology Institute deal?
The deal is expected to value the cancer care chain between ₹1,500 and ₹2,000 crore.
Q2: Who is advising Siemens on this transaction?
Investment bank Alvarez & Marsal is currently advising Siemens on the potential sale of AOI.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Siemens Healthineers plans to exit the American Oncology Institute, valuing the chain at ₹2,000 crore. Explore the impacts on India's cancer care market....
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
